Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Gasperini

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Brain reserve and timing of clinical onset in multiple sclerosisMaria Petracca, Serena Ruggieri, Riccardo Nistri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study resultsRuggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trialRaymond Hupperts, Jan Lycke, Christine Short, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Switch Strategy from Direct Aspiration First Pass Technique to Solumbra Improves Technical Outcome in Endovascularly Treated StrokeEnrico Pampana, Sebastiano Fabiano, Gianluca De Rubeis, et al.
Journal of Neurology|April 12, 2021
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensusDiego Centonze, Maria A Rocca, Claudio Gasperini, et al.
The Neuroradiology Journal|May 16, 2022
Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency settingAlessandro Stasolla, Luca Prosperini, Shalom Haggiag, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 7, 2002
Proteolytic balance in patients with multiple sclerosis during interferon treatmentGianluigi Giannelli, Anna De Marzo, Carolina Scagnolari, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2023
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 19, 2024
Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literatureAlessandro Cruciani, Francesco Motolese, Carla Tortorella, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Brain reserve and timing of clinical onset in multiple sclerosisMaria Petracca, Serena Ruggieri, Riccardo Nistri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study resultsRuggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trialRaymond Hupperts, Jan Lycke, Christine Short, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Switch Strategy from Direct Aspiration First Pass Technique to Solumbra Improves Technical Outcome in Endovascularly Treated StrokeEnrico Pampana, Sebastiano Fabiano, Gianluca De Rubeis, et al.
Journal of Neurology|April 12, 2021
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensusDiego Centonze, Maria A Rocca, Claudio Gasperini, et al.
The Neuroradiology Journal|May 16, 2022
Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency settingAlessandro Stasolla, Luca Prosperini, Shalom Haggiag, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 7, 2002
Proteolytic balance in patients with multiple sclerosis during interferon treatmentGianluigi Giannelli, Anna De Marzo, Carolina Scagnolari, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2023
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 19, 2024
Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literatureAlessandro Cruciani, Francesco Motolese, Carla Tortorella, et al.
Pageof 21